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http://dx.doi.org/10.1016/j.jmii.2013We describe a case of pneumonia and empyema thoracis caused by trimethoprime
sulfamethoxazole-susceptible, but imipenem-resistant Nocardia abscessus in a cancer patient.
The isolate was confirmed to the species level by 16S rRNA sequencing analysis. The patient did
not respond to antibiotic therapy, including ceftriaxone and imipenem, and died of progressing
pneumonia and multiple organ failure.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
The incidence of local and disseminated infections due to
Nocardia species is increasing,especially in immunocompromiseds of Laboratory Medicine and
niversity Hospital, 7 Chung-
tw (P.-R. Hsueh).
an Society of Microbiology. Publ
.01.005individuals.1e4 The most common risk factors for acquiring
Nocardia infections include long-term steroid usage, neoplastic
disease, and human immunodeficiency virus infection.4e6
Advanced molecular methods such as polymerase chain reaction
restriction enzyme analysis and 16S rRNA sequencing have resul-
ted in the identification of a number of new species of the genus
Nocardia in recent years.1 Clinically, accurate identification of
isolates beyond the genus level is essential because strains of
Nocardia species can differ in the clinical presentations of
nocardiosis and in resistance patterns to antibiotics.4,7ished by Elsevier Taiwan LLC. All rights reserved.
Nocardia abscessus in a cancer patient 707N. abscessuswas first proposed as a new species by Yassin et al in
20018; however, little is known about its clinical significance. We
describe a case of empyema thoracis due to N. abscessus in a
cancer patient.
Case report
A 54-year-old man had a medical history of angiosarcoma
status after five courses of doxorubicin, and undergoing
chemotherapy with paciltaxel. Six months prior to admis-
sion, he received video-assisted thoracoscopic surgery for
diagnosis of a right middle lobe mass, which was proved to
be metastatic angiosarcoma. The patient presented to the
hospital with a 1-week history of mild respiratory distress,
chest pain, fever, and purulent discharge from the video-
assisted thoracoscopic surgery incision site on the right
lower chest wall.
Physical examination revealed a body temperature of
38.6C, a pulse rate of 112/min, a respiratory rate of 25/
min, and a blood pressure of 125/73 mmHg. Coarse crackles
were heard in both lung fields, but were more prominent in
the right lower lung. Laboratory studies disclosed the
following values: white blood cell count, 16.49 109/L with
neutrophil predominance (92%); serum urea nitrogen,
190 mg/L; serum creatinine, 5.8 mg/L; alanine amino-
transferase, 18 U/L; sodium, 130 mM; and C-reactive pro-
tein, 93 mg/L (reference value, <8.0 mg/L). Chest
radiography showed multiple nodules and patchy in-
filtrations in both lungs, although they weremore obvious at
the base of the right lung (Fig. 1A).
Ceftriaxone was administered after collecting pus and
sputum cultures. Because of the poor condition of the
wound, the wound was debrided and a chest tube was
inserted for drainage of pleural effusion that was detected
by chest sonography. A diagnosis of empyema thoracis was
made based on demonstration of frank pus upon pleural
fluid aspiration. The clinical condition of the patient,
however, gradually deteriorated and eventually resulted in
acute respiratory failure with shock. The patient wasFigure 1. Chest radiography showing (A) multiple nodules and b
lung on admission, and (B) progressive patchy infiltrations over bilaintubated because of hypoxemic respiratory failure and
admitted to the intensive care unit.
Microbiological staining of the pus and pleural fluid
specimens both disclosed Gram-positive branching bacilli
and acid-fast bacilli (by modified acid-fast stain). Cul-
tures of sputum, pus, and pleural effusion cultures all
grew Gram-positive bacilli with beaded branching fila-
ments and weakly acid-fast rods after incubation for 3
days, suggesting the presence of Nocardia species. In
addition, the isolates were unable to hydrolyze casein,
xanthine, hypoxanthine, or tyrosine. Ceftriaxone was
switched to imipenem/cilastatin to expand the coverage
of probably concurrently encountered nosocomial
copathogens and Nocardia spp. However, the patient’s
condition continued to deteriorate. Follow-up of chest
radiography revealed progressive patchy infiltrations
bilaterally (Fig. 1B). The patient demonstrated symptoms
and signs of multiple organ failure and died on the 20th
hospitalization day.
The isolate was confirmed to be N. abscessus [GenBank
accession numberGU471235.1;maximal identity, 100% (564/
564)] by 16S rRNA gene sequence analysis as reported pre-
viously.4,7 The minimum inhibitory concentration (MIC) was
4.0 mg/L for trimethoprimesulfamethoxazole,>32 mg/L for
both ciprofloxacin and imipenem, and 1.5 mg/L for ceftri-
axone as determined by the E-test (AB Biodisk, Solna,
Sweden).
Discussion
The clinical manifestations of infections caused by
N. abscessus include respiratory tract infection, primary
cutaneous infection, pericarditis, cerebral abscess, ocular
infection, and disseminated infection.2,9e16 In a previously
reported multicenter study of the clinical presentations of
infections due to various Nocardia species during a 13-year
period in Taiwan,4 one case of N. abscessus-related brain
abscess was identified. In the present report, we used
conventional biochemical studies and molecular methods toilateral patchy infiltrations, especially at the base of the right
teral lung fields on the day of death (20th hospitalization day).
708 C.-C. Lai et al.confirm that the empyema thoracis and pulmonary infec-
tion in our patient were due to N. abscessus.
Previous studies have demonstrated that patients with
human immunodeficiency virus infection, those on cortico-
steroid therapy, patientswith chronic obstructive pulmonary
diseases, systemic lupus erythematosus, rheumatoid
arthritis, or lung cancer are at increased risk for developing
infections due to N. abscessus.2,11,12 In our patient, the
condition of angiosarcoma and chemotherapy was consid-
ered themain predisposing factor for N. abscessus infection.
We previously reported that trimethoprimesulfame-
thoxazole had good in vitro activity against the most
common clinical isolates of Nocardia species, such as
Nocardia brasiliensis, but that its activity against other
Nocardia species varied.7 We also found that three N.
abscessus isolates were susceptible to sulfamethoxazole,
imipenem, ceftriaxone, and amikacin.7 By contrast, a study
conducted in Spain showed that all six of the clinical iso-
lates of N. abscessus analyzed were resistant to imipenem
with MIC values 32 mg/m.2 In addition, a study conducted
in India reported that two clinical isolates of N. abscessus
were susceptible to amikacin and tobramycin but that they
showed different resistance patterns against azithromycin,
clarithromycin, ciprofloxacin, and gatifloxacin.15 In the
present study, we found that N. abscessus isolates were
susceptible to trimethoprimesulfamethoxazole and ceftri-
axone but resistant to imipenem (MIC >32 mg/mL) that was
administered in our patient. Overall, no solid conclusion on
the susceptibility profiles of N. abscessus can be drawn
based on the limited number of in vitro studies. The lack of
use of trimethoprimesulfamethoxazole that was active
against the N. abscessus isolate might partly contribute to
the treatment failure of this patient. Further large-scale
studies are needed to evaluate the antibiotic resistance
pattern of N. abscessus.
In conclusion, we have described a fatal case of
pneumonia and empyema thoracis caused by trimetho-
primesulfamethoxazole-susceptible, but imipenem-
resistant N. abscessus in a cancer patient. Sequencing of
the 16S rRNA gene is essential for the identification of
bacteria in the Nocardia genus to the species level.
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